UCB (XBRU:UCB) Shares Buyback Ratio % : -0.10 (As of Apr. 30, 2024)

View and export this data going back to 1988. Start your Free Trial

What is UCB Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. UCB's current shares buyback ratio was -0.10%.

UCB Shares Buyback Ratio % Historical Data

The historical data trend for UCB's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UCB Shares Buyback Ratio % Chart

UCB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

0.17

-0.23

-0.08

-0.22

-0.10

UCB Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.19	-0.41	0.19	-0.07	-0.03

UCB Shares Buyback Ratio % Calculation

UCB's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(189.595	-	189.777)	/	189.595
	=	-0.10%

UCB's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(189.721	-	189.777)	/	189.721
	=	-0.03%

UCB Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of UCB's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

UCB (XBRU:UCB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (XBRU:UCB) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

UCBJY:USA UCBJF:USA UCBb:UK 0NZT:UK UNC:Germany UCB:Austria

Address

Allee de la Recherche, 60, Brussels, BEL, B-1070

Website

https://www.ucb.com

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).

UCB (XBRU:UCB) Headlines

No Headlines